We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
Sekisui Diagnostics UK Ltd.

Randox Laboratories

Provides global diagnostic solutions for hospital laboratories, forensic laboratories, research laboratories, pharmac... read more Featured Products: More products

Download Mobile App

Randox Exhibits Full Range of Molecular Diagnostic Solutions

By LabMedica International staff writers
Posted on 14 Nov 2023
Print article
Image: Randox is exhibiting its extensive range of products and services at Hall 3 Stand A08 at MEDICA 2023 (Photo courtesy of Randox)
Image: Randox is exhibiting its extensive range of products and services at Hall 3 Stand A08 at MEDICA 2023 (Photo courtesy of Randox)

Randox Laboratories (Crumlin, UK) is exhibiting its full range of molecular diagnostic solutions at MEDICA 2023. Designed to meet the demands of today’s molecular diagnostic laboratory, the Randox range of molecular products comprises IQC and EQA for molecular infectious disease testing as well as point of care, semi and fully automated analyzers.

As a provider of high-quality diagnostic solutions, Randox offers a wide range of products and services, including quality control, molecular diagnostics, third-party reagents, point of care, and clinical chemistry analyzers. At MEDICA 2023, Randox is demonstrating the Vivalytic all-in-one molecular solution that consolidates full molecular workflow into one small benchtop platform. Randox’s multiplex Biochip Technology powers the Vivalytic, enabling multiple results from one patient sample. Randox is also highlighting the new Acusera true third-party controls alongside the ACUSERA 24•7 Interlaboratory Data Management for external quality assessment with features such as; interactive Levey-Jennings charts, automatic calculation for uncertainty of measurement as well as the comprehensive reports generated on demand.

In addition, Randox is showcasing the RX misano high-performance semi-automated clinical chemistry analyzer that is capable of high-standard, precise results at a competitive price per test. It can expand testing capabilities with the ability to run both routine and specialized tests including chemistries, specific proteins, antioxidants, veterinary and diabetes testing, and analyzing a variety of sample types, including serum, plasma, and urine. Randox is also highlighting the RX monaco fully automated clinical chemistry analyzer that comprises an extensive test menu covering routine chemistries, specific proteins, lipids, antioxidants, diabetes, and veterinary testing with emergency and STAT sampling. The RX monaco is ideal for low to mid-volume clinical chemistry testing consolidating routine and specialized testing onto one efficient and easy-to-use platform.

Related Links:
Randox Laboratories 

Platinum Member
Flu SARS-CoV-2 Combo Test
OSOM® Flu SARS-CoV-2 Combo Test
Magnetic Bead Separation Modules
POCT Fluorescent Immunoassay Analyzer
Gold Member
TORCH Panel Rapid Test
Rapid TORCH Panel Test

Print article


Clinical Chemistry

view channel
Image: The new ADLM guidance will help healthcare professionals navigate respiratory virus testing in a post-COVID world (Photo courtesy of 123RF)

New ADLM Guidance Provides Expert Recommendations on Clinical Testing For Respiratory Viral Infections

Respiratory tract infections, predominantly caused by viral pathogens, are a common reason for healthcare visits. Accurate and swift diagnosis of these infections is essential for optimal patient management.... Read more

Molecular Diagnostics

view channel
Image: The HelioLiver Dx test has met the coprimary and secondary study endpoints in the CLiMB trial (Photo courtesy of Helio Genomics)

Blood-Based Test Outperforms Ultrasound in Early Liver Cancer Detection

Patients with liver cirrhosis and chronic hepatitis B are at a higher risk for developing hepatocellular carcinoma (HCC), the most prevalent type of liver cancer. The American Association for the Study... Read more


view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more


view channel
Image: The POC PCR test shortens time for STI test results (Photo courtesy of Visby Medical)

POC STI Test Shortens Time from ED Arrival to Test Results

In a 2024 sexually transmitted infections (STIs) surveillance report by the World Health Organization (WHO), over 2.5 million cases were recorded, alongside a rise in the inappropriate use of antibiotics... Read more


view channel
Image: For 46 years, Roche and Hitachi have collaborated to deliver innovative diagnostic solutions (Photo courtesy of Roche)

Roche and Hitachi High-Tech Extend 46-Year Partnership for Breakthroughs in Diagnostic Testing

Roche (Basel, Switzerland) and Hitachi High-Tech (Tokyo, Japan) have renewed their collaboration agreement, committing to a further 10 years of partnership. This extension brings together their long-standing... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.